StateHouse announced that it has entered into a sales agency agreement with Stinson Brands, a management company that consults, and holds IP, for the development premium food and beverage brands with an emphasis on fine herbal tea blends. Under the terms of the strategic sales agency agreement, StateHouse will begin selling Stinson Brands products through its sales team and in its Harborside and Urbn Leaf dispensaries across California. StateHouse will work with its valued distribution partner, Nabis, to develop this new line of business, and expects to expand into new product categories while growing Stinson’s well-known portfolio of brands including Kikoko, a cannabis botanical wellness company focused on offering women plant-based, scientifically proven alternatives to pharmaceuticals and alcohol, to new levels of success. “Kikoko is a top-selling California brand that continues to innovate its product offerings across multiple categories,” said Ed Schmults, CEO of StateHouse. “StateHouse welcomes Kikoko to its roster of brands and believes this partnership will catapult Kikoko to new levels of visibility in the market while simultaneously fulfilling our promise to our patients and customers to provide the highest-quality cannabis products.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on STHZF:
- StateHouse and Stinson Brands, Inc. Enter Into Strategic Sales Agency Agreement
- StateHouse Holdings Appoints Zed Schlott as Vice President of Retail
- StateHouse Announces Fall 2023 Conference Participation
- Pelorus retains StateHouse for Humboldt County cultivation facility
- StateHouse Reports Second Quarter 2023 Financial Results
